HS

Harender Singh

Director Director DIN 02409125
DIN 02409125 First appointment Jan 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Harender Singh

Data last updated:

Harender Singh was a Director at Animax Health Care Private Limited (2009–2013) and Director at Ablay Pharma Private Limited (from 2009). The companies operate in Pharma.

DIN 02409125
Primary Designation Director
Industry Pharma
First Appointment 12 Jan 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Animax Health Care Private Limited U24100DL2009PTC191939
Director06 Jul 20092009₹13.72 Cr (FY 2025)Active
Ablay Pharma Private Limited U24239JK2009PTC002967
Director12 Jan 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ablay Pharma Private Limited
Animax Health Care Private Limited
Premium access

Shareholding and investment profile for Harender Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harender Singh

Harender Singh was first appointed on 12 Jan 2009 as Director at Ablay Pharma Private Limited.

Harender Singh held 2 earlier board appointments: Animax Health Care Private Limited (Director, 06 Jul 2009 to 27 Aug 2013); Ablay Pharma Private Limited (Director, from 12 Jan 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available